10.1016/j.peptides.2013.12.015 32
Side effects are a manageable part of GLP-1 treatment, not a reason to avoid it or stop it prematurely
McCormick LM, Hoole SP, White PA, Read PA, Axell RG, Clarke SJ, OSullivan M, West NEJ, Dutka DP
In response to lipopolysaccharide stimulation, exendin-4 reduced the expression of IL-1 and TNF- in these cells (85)
Cursos relacionados Curso Online: Suplementacin Metablica de la Resistencia a la Insulina al SOP Rated 0 out of 5 Oferta
Advancing GLP-1 Analog Drug Development Using a Variety of Light Scattering Techniques Presented by : Xujun Zhang Ph.D., Waters | Wyatt Technology Presented Live : January 8, 2025 Characterizing biological macromolecules used in therapeutics is both essential and complex